Disruption of Cellular Messenger RNA Processing Events by the Kaposi's Sarcoma-As

卡波西肉瘤对细胞信使 RNA 加工事件的破坏

基本信息

  • 批准号:
    8072711
  • 负责人:
  • 金额:
    $ 29.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-12 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiologic agent of the most common neoplasm in untreated AIDS patients, and is also affiliated with two B cell lymphoproliferative disorders. The lytic viral replication cycle has previously been shown to be an essential component of KSHV-induced pathogenesis. One prominent consequence of lytic KSHV infection is a near total destruction of the cellular transcriptome, termed 'host shutoff'. This phenotype is mediated by the viral SOX protein which promotes enhanced cellular messenger RNA (mRNA) degradation, likely via interception of cellular RNA stability pathways. We have identified 2 novel SOX activities linked to host shutoff: SOX induces nuclear re-localization of cytoplasmic poly(A) binding protein (PABPC), and triggers disruption of the 3' end processing of cellular mRNAs in the nucleus leading to their hyperadenylation. PABPC is a cellular protein that plays a key role in mRNA translation and stability in the cytoplasm yet has no known nuclear functions. Thus, we hypothesize that its aberrant localization in SOX-expressing cells is a significant contributor to cytoplasmic mRNA destruction. Within the nucleus, the nascent hyperadenylated cellular mRNAs are not exported, and we predict they are destroyed by cellular quality control mechanisms. Interestingly, we have preliminary data indicating that nuclear PABPC is an important driver of the hyperadenylation phenotype. Thus, KSHV appears to target PABPC to eliminate both nuclear and cytoplasmic cellular messages via distinct mechanisms. This represents a completely novel mechanism of virus-induced termination of host gene expression and, additionally, reveals for the first time in human cells a mechanism for polyadenylation-stimulated mRNA decay and a role for PABPC in the nucleus. Emerging connections between disruption of normal cellular RNA turnover pathways and human disease have highlighted the importance of understanding mechanisms by which such events become deregulated; it is in this regard that KSHV SOX represents an excellent tool to probe how pathogenic human viruses may interface with these critical cellular pathways. This proposal will explore the connections between SOX-induced PABPC import and mRNA hyperadenylation, as well as explore the contribution of cellular quality control pathways towards the ultimate destruction of these messages. Specifically, we will begin by confirming that nuclear PABPC drives hyperadenylation then proceed to dissect the mechanisms by which this occurs. PABPC is a key antagonist of the nonsense-mediated mRNA decay pathway in the cytoplasm, and we will therefore explore the potential aberrant activation of this and other quality control pathways during KSHV infection. Finally, we will monitor the contribution of host shutoff towards viral replication and pathogenesis both in cell culture and in murine models. PUBLIC HEALTH RELEVANCE: Viruses not only cause disease, but are also superb tools to probe the inner workings of our own cells. We investigate how a cancer causing human herpesvirus destroys cellular messages to enhance its own replication, as this information will provide important clues both into how this virus thrives in infected individuals and also how cellular gene expression is regulated.
描述(由申请人提供):卡波西肉瘤相关疱疹病毒(KSHV)是未经治疗的艾滋病患者中最常见的肿瘤的病因,也与两种B细胞淋巴增生性疾病有关。裂解病毒复制周期先前已被证明是kshv诱导的发病机制的重要组成部分。溶解性KSHV感染的一个突出后果是细胞转录组几乎完全破坏,称为“宿主关闭”。这种表型是由病毒SOX蛋白介导的,该蛋白促进增强的细胞信使RNA (mRNA)降解,可能通过拦截细胞RNA稳定途径。我们已经确定了与宿主关闭相关的两种新的SOX活性:SOX诱导细胞质多聚(A)结合蛋白(PABPC)的核重新定位,并触发细胞核中细胞mrna的3'端加工中断,导致其高腺苷化。PABPC是一种细胞蛋白,在mRNA翻译和细胞质稳定性中起关键作用,但没有已知的核功能。因此,我们假设它在表达sox的细胞中的异常定位是细胞质mRNA破坏的重要因素。在细胞核内,新生的高腺苷化细胞mrna不会输出,我们预测它们会被细胞质量控制机制破坏。有趣的是,我们有初步数据表明核PABPC是高腺苷化表型的重要驱动因素。因此,KSHV似乎以PABPC为目标,通过不同的机制消除细胞核和细胞质细胞信息。这代表了一种病毒诱导宿主基因表达终止的全新机制,此外,首次揭示了人类细胞中聚腺苷酸刺激的mRNA衰变机制和PABPC在细胞核中的作用。正常细胞RNA转换途径的破坏与人类疾病之间的新联系突出了理解这些事件解除管制的机制的重要性;正是在这方面,KSHV SOX代表了一个极好的工具来探索致病性人类病毒如何与这些关键的细胞途径相结合。本研究将探讨sox诱导的PABPC输入与mRNA高腺苷化之间的联系,以及细胞质量控制途径对这些信息最终破坏的贡献。具体来说,我们将首先确认核PABPC驱动超腺苷化,然后继续剖析这种情况发生的机制。PABPC是细胞质中无意义介导的mRNA衰变途径的关键拮抗剂,因此我们将探索KSHV感染期间该途径和其他质量控制途径的潜在异常激活。最后,我们将在细胞培养和小鼠模型中监测宿主关闭对病毒复制和发病机制的贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Britt A Glaunsinger其他文献

Britt A Glaunsinger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Britt A Glaunsinger', 18)}}的其他基金

2023 Viruses and Cells Gordon Research Conference and Gordon Research Seminar
2023病毒与细胞戈登研究大会暨戈登研究研讨会
  • 批准号:
    10609208
  • 财政年份:
    2023
  • 资助金额:
    $ 29.04万
  • 项目类别:
Functional Characterization of Herpesvirus-Activated Noncoding Retrotransposon RNAs
疱疹病毒激活的非编码反转录转座子 RNA 的功能表征
  • 批准号:
    9975697
  • 财政年份:
    2019
  • 资助金额:
    $ 29.04万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    9178643
  • 财政年份:
    2015
  • 资助金额:
    $ 29.04万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    10368981
  • 财政年份:
    2015
  • 资助金额:
    $ 29.04万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    10223851
  • 财政年份:
    2015
  • 资助金额:
    $ 29.04万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    9049040
  • 财政年份:
    2015
  • 资助金额:
    $ 29.04万
  • 项目类别:
Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus
卡波西肉瘤相关疱疹病毒对细胞 RNA 加工的破坏
  • 批准号:
    9317435
  • 财政年份:
    2015
  • 资助金额:
    $ 29.04万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    10576837
  • 财政年份:
    2015
  • 资助金额:
    $ 29.04万
  • 项目类别:
Escape from gammaherpesvirus-induced mRNA destruction
逃避伽马疱疹病毒诱导的 mRNA 破坏
  • 批准号:
    8148069
  • 财政年份:
    2011
  • 资助金额:
    $ 29.04万
  • 项目类别:
Escape from gammaherpesvirus-induced mRNA destruction
逃避伽马疱疹病毒诱导的 mRNA 破坏
  • 批准号:
    8309954
  • 财政年份:
    2011
  • 资助金额:
    $ 29.04万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 29.04万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 29.04万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 29.04万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 29.04万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 29.04万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 29.04万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 29.04万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 29.04万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 29.04万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 29.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了